학술논문
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer
Document Type
Article
Author
Macaya, I.; Roman, M.; Welch, C.; Entrialgo-Cadierno, R.; Feliu, I.; Lopez, I.; Rodriguez-Remirez, M.; Narayanan, S.; Ponz-Sarvise, M.; Lecanda, F.; Gil-Bazo, I.; Vicent, S.; Salmon, M.; Drosten, M.; Barbacid, M.; Santos, A.; Ferrero, M.; Calabuig, S.; Jantus-Lewintre, E.; Ferrer, I.; Paz-Ares, L.; Kovalski, J.; Ruggero, D.; Khatri, P.; Palomino-Echeverria, S.; Lonfgren, S.M.; Ludwig, I.A.; Pineda-Lucena, A.; Lara-Astiaso, D.; Guruceaga, E.; Santamaria, E.; Fernandez-Irigoyen, J.
Source
In: Nature Communications . (Nature Communications, December 2023, 14(1))
Subject
Language
English
ISSN
20411723